| # | Drug | Count |
|---|---|---|
| 0 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 2 |
| 1 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 2 |
| 2 | MARAVIROC | 2 |
| 3 | RALTEGRAVIR | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARAVIROC | 2 | 0.0009 |
| 1 | RALTEGRAVIR | 2 | 0.0004 |
| 2 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 2 | 0.0003 |
| 3 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |